Janux Therapeutics (JANX) announced the promotion of Dr. Zachariah McIver to Chief Medical Officer. Dr. McIver joined Janux after serving as Amgen’s (AMGN) Executive Medical Director for over 4 years, leading cross-functional teams in the design, implementation, and execution of clinical and correlative study strategies.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JANX:
- Opco lists five potential biotech targets into JPMorgan conference
- Janux Therapeutics CEO sells $1.4M in common stock
- Janux Therapeutics 5.32M share Secondary priced at $63.00
- Salesforce up after Q3, GM outlines $5B in China business charges: Morning Buzz
- Janux Therapeutics announces $300M common stock offering